Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity

v3.21.2
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Beginning balance at Jan. 31, 2020 $ 49,932 $ 373 $ 245,067 $ (147) $ (2,137) $ (193,224)
Beginning balance, Shares at Jan. 31, 2020   37,303,952        
Issuance of common stock pursuant to vesting of restricted stock units   $ 4 (4)      
Issuance of common stock pursuant to vesting of restricted stock units, Shares   379,063        
Issuance of common stock pursuant to ESPP purchases 18   18      
Issuance of common stock pursuant to ESPP purchases, shares   5,702        
Issuance of common stock pursuant to exercise of stock options 119   119      
Issuance of common stock pursuant to exercise of stock options, shares   39,270        
Stock-based compensation expense 1,054   1,054      
Repurchases of common stock (80)     (80)    
Unrealized gain(losses) on marketable securities (37)       (37)  
Foreign currency translation adjustment 1,498       1,498  
Net loss (17,393)         (17,393)
Ending balance at Oct. 31, 2020 35,111 $ 377 246,254 (227) (676) (210,617)
Ending balance, Shares at Oct. 31, 2020   37,727,987        
Beginning balance at Jul. 31, 2020 39,967 $ 377 245,817 (227) (500) (205,500)
Beginning balance, Shares at Jul. 31, 2020   37,727,987        
Stock-based compensation expense 437   437      
Unrealized gain(losses) on marketable securities (33)       (33)  
Foreign currency translation adjustment (143)       (143)  
Net loss (5,117)         (5,117)
Ending balance at Oct. 31, 2020 35,111 $ 377 246,254 (227) (676) (210,617)
Ending balance, Shares at Oct. 31, 2020   37,727,987        
Beginning balance at Jan. 31, 2021 31,541 $ 378 246,446 (227) (73) (214,983)
Beginning balance, Shares at Jan. 31, 2021   37,811,224        
Issuance of common stock pursuant to vesting of restricted stock units   $ 10 (10)      
Issuance of common stock pursuant to vesting of restricted stock units, Shares   981,927        
Issuance of common stock pursuant to exercise of stock options 137 $ 1 136      
Issuance of common stock pursuant to exercise of stock options, shares   95,538        
Issuance of common stock, net of issuance costs 17,462 $ 103 17,359      
Issuance of common stock, net of issuance costs, shares   10,323,484        
Stock-based compensation expense 1,315   1,315      
Unrealized gain(losses) on marketable securities 1       1  
Foreign currency translation adjustment (649)       (649)  
Net loss (5,946)         (5,946)
Ending balance at Oct. 31, 2021 43,861 $ 492 265,246 (227) (721) (220,929)
Ending balance, Shares at Oct. 31, 2021   49,212,173        
Beginning balance at Jul. 31, 2021 45,983 $ 492 264,972 (227) (430) (218,824)
Beginning balance, Shares at Jul. 31, 2021   49,212,173        
Stock-based compensation expense 274   274      
Foreign currency translation adjustment (291)       (291)  
Net loss (2,105)         (2,105)
Ending balance at Oct. 31, 2021 $ 43,861 $ 492 $ 265,246 $ (227) $ (721) $ (220,929)
Ending balance, Shares at Oct. 31, 2021   49,212,173